Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:08:34 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:RPRX - ROYALTY PHARMA PLC - http://www.reprosrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RPRX - Q0.655.21·55.243.155.20+0.340.61,009.854,57911,92555.33  55.515  54.3556.07  33.3712:48:02Jun 0415 min RT 2¢

Recent Trades - Last 10 of 11925
Time ETExPriceChangeVolume
12:48:12Q55.20010.340114
12:48:07Q55.2250.3652
12:48:02Q55.2250.36538
12:48:02Q55.2250.36538
12:48:02Q55.22040.360420
12:48:02Q55.2250.3654
12:48:00Q55.200.3423
12:48:00Q55.200.3410
12:48:00Q55.19990.339920
12:48:00Q55.200.34100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-04 16:15U:RPRXNews ReleaseRoyalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
2026-05-07 16:15U:RPRXNews ReleaseRoyalty Pharma to present at upcoming investor conferences
2026-05-06 07:00U:RPRXNews ReleaseRoyalty Pharma reports first quarter 2026 results
2026-04-21 13:00U:RPRXNews ReleaseRoyalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
2026-04-17 08:30U:RPRXNews ReleaseRoyalty Pharma Declares Second Quarter 2026 Dividend
2026-04-15 16:15U:RPRXNews ReleaseRoyalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
2026-03-30 07:15U:RPRXNews ReleaseRoyalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
2026-03-23 07:15U:RPRXNews ReleaseRoyalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
2026-03-17 16:01U:RPRXNews ReleaseRoyalty Pharma Announces Expansion of Leadership Team
2026-03-02 07:00U:RPRXNews ReleaseRoyalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
2026-03-02 06:10U:RPRXNews ReleaseRoyalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
2026-03-02 06:01U:RPRXNews ReleaseZymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
2026-02-26 16:15U:RPRXNews ReleaseRoyalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference
2026-02-11 07:00U:RPRXNews ReleaseRoyalty Pharma Reports Q4 and Full Year 2025 Results
2026-01-20 16:15U:RPRXNews ReleaseRoyalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
2026-01-12 07:15U:RPRXNews ReleaseRoyalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference
2026-01-11 17:15U:RPRXNews ReleaseRoyalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
2026-01-11 17:00U:RPRXNews ReleaseTeva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
2026-01-09 08:30U:RPRXNews ReleaseRoyalty Pharma Announces Dividend Increase
2025-12-29 16:40U:RPRXNews ReleaseRoyalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones